Dianthus Therapeutics (DNTH) total debt

Total debt · fiscal 2025
$1.39M

Dianthus Therapeutics (DNTH) carried total debt of $1.39M at the end of fiscal 2025 (December 31, 2025). That is 7.0% lower than the $1.49M of fiscal 2024. Figures as of 18 Nov 2026, 00:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$1.39M
Change on fiscal 2024
−7.0%
Highest on record
$1.49Mfiscal 2024
Lowest on record
$585.00Kfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Dianthus Therapeutics total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $1.49M in fiscal 2024 and the lowest $585.00K in fiscal 2023.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Dianthus Therapeutics total debt, year by year

Dianthus Therapeutics (DNTH) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$1.39M 7.0% down0.0×
2024$1.49M 154.9% up0.0×
2023$585.00K 25.8% down0.0×
2022$788.00K—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Dianthus Therapeutics and comparable companies
CompanyTotal debtFiscal year
LivaNova LIVN$433.77M2025
Ionis Pharmaceuticals IONS$2.06B2025
Dianthus Therapeutics DNTH$1.39M2025
MiniMed Group MMED$145.00M2026
Adaptive Biotechnologies ADPT$79.15M2025
Heartflow HTFL$22.05M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DNTH

Dianthus Therapeutics, figure by figure

Dianthus Therapeutics (DNTH) overview: price, valuation and scorecardAll health care companies by market value

Dianthus Therapeutics total debt: questions and answers

How much debt does Dianthus Therapeutics have?

Dianthus Therapeutics (DNTH) carried total debt of $1.39M at the end of fiscal 2025 (December 31, 2025). That is 7.0% lower than the $1.49M of fiscal 2024.

What are the highest and lowest total debt figures on record for Dianthus Therapeutics?

Across the 4 fiscal years on record (2022–2025), the highest was $1.49M in fiscal 2024 and the lowest $585.00K in fiscal 2023.

How does Dianthus Therapeutics's debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Dianthus Therapeutics's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dianthus Therapeutics (DNTH) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/DNTH/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.